Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €125.60 | €140.60 | 11.945% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €394.10 | €408.36 | 3.618% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €206.10 | €294.01 | 42.654% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.36 | €200.06 | 27.947% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 5 | 0 | €910.00 | €959.41 | 5.430% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €698.60 | €760.00 | 8.789% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €284.60 | €297.31 | 4.467% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €16.81 | €28.06 | 66.991% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.09 | €86.77 | 39.750% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.42 | €35.43 | 39.376% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €53.50 | €85.64 | 60.081% |
| Insmed Inc. | 16 | 1 | 4 | 0 | €23.60 | €44.01 | 86.469% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €148.48 | €174.43 | 17.480% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €11.33 | €27.80 | 145.402% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €22.00 | €45.21 | 105.500% |
| Novavax Inc. | 6 | 2 | 4 | 1 | €13.02 | €49.80 | 282.399% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €24.00 | €68.78 | 186.580% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.21 | €40.66 | 55.159% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.46 | €26.01 | 33.640% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.40 | €421.61 | 16.017% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €45.50 | €41.54 | -8.714% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |